Curley Joanne 4
4 · Vistagen Therapeutics, Inc. · Filed Sep 10, 2024
Insider Transaction Report
Form 4
Curley Joanne
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-06+14,100→ 14,100 totalExercise: $3.25Exp: 2034-09-06→ Common Stock (14,100 underlying)
Footnotes (1)
- [F1]Represents stock options ("Options") granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended. Twenty-five percent (25%) of the Options vest on the date of issuance ("Grant Date"), with the remainder vesting in twelve (12) equal monthly installments thereafter, until the Options become fully vested on the one (1) year anniversary of the Grant Date.